Ozlem Yilman

Ozlem Yilman

Auto-generated profile, based on publicly available information

Ozlem Yilman

Department of Neonatology, University of Health Sciences, İzmir Faculty of Medicine, Dr. Behçet Uz Children's Hospital, İzmir, Türkiye

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2025 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
İDİlker Devrim
İlker Devrim
AOArife Ozer
Arife Ozer
DEDeniz Ergun
Deniz Ergun
HOHincal Ozbakir
Hincal Ozbakir
BCBerna Kahraman Cetin
Berna Kahraman Cetin
NBNuri Bayram
Nuri Bayram

1 January 2022 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
SOSENEM Alkan Ozdemir
SENEM Alkan Ozdemir
ÖYÖzlem Yilman
Özlem Yilman
ŞÇŞebnem Çalkavur
Şebnem Çalkavur
TYTüli̇n Gökmen Yildirim
Tüli̇n Gökmen Yildirim
Background/aim: We aimed to discuss term infants who are given surfactant due to respiratory disorder according to the underlying etiology, the dose of surfactant administration, and the need for repeated surfactant administration. Materials and methods: In this retrospective study infants hospitalized in the 4th level neonatal intensive care unit during January 2019 and December 2021 and administered surfactant due to respiratory distress were included. Term infants given surfactant due to respiratory failure were included in the study through the data recording system. The number of surfactant doses, indications for administration, mortality, duration of hospitalization, intubation time, and inotrope use were recorded in the infants included in the study. Results: During the two-year period, 1250 infants were hospitalized in our neonatal intensive care unit. Of those, 56 infants received surfactant replacement therapy for severe respiratory failure. There were 30 infants with pneumonia, 4 infants with meconium aspiration syndrome (MAS), and 22 infants with transient tachypnea of the newborn (TTN). It was seen that single-dose administration was higher in patients with TTN (p = 0.01), while multiple-dose surfactant administration was more common in patients with MAS, resulting in a statistical difference (p = 0.02). Mortality was lower, especially in cases given early surfactant administration and this situation was statistically significant (p < 0.001). Duration of intubation was 5.05 ± 4.7 days in early surfactant administration group and 8.0 ± 6.1 days in late surfactant administration group. This difference was statistically significant (p = 0.04). While early surfactant application was statistically higher in the TTN group (p = 0.007), late surfactant application was statistically higher in the pneumonia group (p = 0.001). Conclusion: Despite the difference on administration time and repeat dose interval due to etiology, surfactant treatment is improving the respiratory distress of term infants.

13 December 2023 in Gynecology Obstetrics & Reproductive Medicine
Verified
Journal Article
Open access
PDF file
OYOzlem Yilman
Ozlem Yilman
SOSENEM Alkan Ozdemir
SENEM Alkan Ozdemir
SCSebnem Calkavur
Sebnem Calkavur
TYTulin Gokmen Yildirim
Tulin Gokmen Yildirim
OBJECTIVE: We aimed to evaluate surfactant frequency and surfactant indications, as well as lung problems in late preterm infants. STUDY DESIGN: This retrospective and cross-sectional study was carried out by HSU Izmir Dr. Behcet Uz Pediatric Diseases and Surgery Research and Training Hospital. Infants who were born late preterm between January 2016 and January 2022 were hospitalized in the NICU due to respiratory distress in the first 24 hours. Lung problems and surfactant administration of these infants were evaluated. The frequency of surfactant dosages, their indications, and their effects were examined. As the control group, patients who were admitted to the NICU in the same period due to respiratory distress with similar indications but did not receive surfactant were considered. RESULTS: It was observed that surfactant was not administered to 105 infants and surfactant was administered to 106 infants. The median gestational week of the infants included in the study was 35 (34/36) weeks and the birth weight was 2185 (1780/2590) grams. A significant difference was observed in birth weight between the groups (p<0.001). Invasive ventilation was required in 52.1% of all cases and noninvasive ventilation was required in 33.6%. In the delivery room, the need for resuscitation and intubation was higher in the group requiring surfactant (p=0.001). The most common lung pathology in the surfactant group was RDS. CONCLUSION: It must not be forgotten that infants who are born late preterm infants are preterm infants and the evaluation of antenatal steroid administration must not be ignored.

18 October 2026 in Turkish Journal of Pediatric Surgery
Verified
Journal Article
Open access
PDF file
OOOzkan Okur
Ozkan Okur
TYTolga Yüksel
Tolga Yüksel
ÖYÖzlem Yılman
Özlem Yılman
IGIncinur Genişol
Incinur Genişol
MCMehmet Can
Mehmet Can
AŞArzu Şencan
Arzu Şencan
Objectives: This study aimed to evaluate the clinical and radiologic characteristics of neonates with pneumothorax (PNX) requiring tube thoracostomy and to identify factors independently associated with chest tube duration. Patients and Methods: In this retrospective single-center study, neonates who underwent tube thoracostomy for PNX between January 2020 and January 2026 were evaluated. Radiologic and follow-up variables, including PNX size, persistent air leak, and early lung re-expansion, were reviewed. The primary outcome was chest tube duration. Factors associated with duration were analyzed using univariable tests and a multivariable linear regression model. Results: Fifty-eight neonates (38 males, 20 females; median gestational age: 37 weeks; interquartile range [IQR], 31-39) were included. Among 55 survivors, the median chest tube duration was six days (IQR, 4 to 12). Longer chest tube duration was associated with larger PNX size ( p = 0.020), persistent air leak ≥ 72 h (16.5 vs. 5.0 days, p < 0.001), and absence of early lung re-expansion (9.0 vs. 5.5 days, p = 0.033), whereas timing of onset, mediastinal shift, and laterality were not. In multivariable analysis, only persistent air leak remained independently associated with prolonged duration, whereas PNX size and early lung re-expansion were no longer significant after adjustment. Conclusion: Drainage duration appears to depend more on post-procedural resolution dynamics than on baseline presentation features. Persistent air leak and the absence of early lung re-expansion are best regarded as markers of unresolved PNX rather than independent determinants and may help identify infants likely to require prolonged drainage. These findings should be interpreted cautiously given the observational design.

28 January 2026 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
HOHincal Ozbakir
Hincal Ozbakir
YAYigit Aksoy
Yigit Aksoy
DEDeniz Ergun
Deniz Ergun
STSinem Aksoy Timur
Sinem Aksoy Timur
OYOzlem Yilman
Ozlem Yilman
İDİlker Devrim
İlker Devrim